|
Orphengesic ForteDrug - Orphengesic Forte The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Aspirin; Caffeine; Orphenadrine Citrate
Strength -
770MG;60MG;50MG
Applicant -
PAR PHARM
New Drug Application (NDA) Number -
075141
Product Number -
002
Therapeutic Equivalence (TE) Code -
AB
Approval Date -
May 29, 1998
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Par Pharmaceutical Inc
Orphengesic Forte
Invagesic Forte 770mg;60mg;50mg Tablet; Oral
Norgesic 385mg;30mg;25mg Tablet; Oral Norgesic Forte 770mg;60mg;50mg Tablet; Oral Orphenadrine Citrate, Aspirin, And Caffeine 385mg;30mg;25mg Tablet; Oral Orphenadrine Citrate, Aspirin, And Caffeine 770mg;60mg;50mg Tablet; Oral Orphenadrine Citrate, Aspirin, And Caffeine 385mg;30mg;25mg Tablet; Oral Orphenadrine Citrate, Aspirin, And Caffeine 770mg;60mg;50mg Tablet; Oral Orphengesic 385mg;30mg;25mg Tablet; Oral Orphengesic Forte 770mg;60mg;50mg Tablet; Oral Invagesic 385mg;30mg;25mg Tablet; Oral NewDrugInformation |